TEXAS INSTRUMENTS INCTXN
Market cap
$168.7B
P/E ratio
| Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Net income | 3,228 | 2,236 | 1,759 | 2,162 | 2,821 | 2,986 | 3,595 | 3,682 | 5,580 | 5,017 | 5,595 | 7,769 | 8,749 | 6,510 | 4,799 |
| Depreciation | 865 | 904 | 957 | 879 | 850 | 766 | 605 | 539 | 590 | 708 | 733 | 755 | 925 | 1,175 | 1,508 |
| Amortization of capitalized software | - | - | - | - | - | - | 31 | 47 | 46 | 54 | 61 | 57 | 54 | 63 | 72 |
| Stock compensation | 190 | 269 | 263 | 287 | 277 | 286 | 252 | 242 | 232 | 217 | 224 | 230 | 289 | 362 | 387 |
| Gains on sales of assets | - | - | - | 6 | 73 | 85 | 40 | - | 3 | 23 | 4 | 57 | 3 | - | 127 |
| Deferred taxes | -188 | -119 | 65 | 50 | -61 | -55 | -202 | 112 | -105 | 81 | -137 | 15 | -191 | -299 | -210 |
| Accounts receivable | -231 | -112 | -311 | -16 | 49 | -77 | 108 | 7 | -71 | -133 | 340 | 287 | 194 | -108 | -68 |
| Inventories | -304 | 17 | -5 | -26 | 53 | -93 | 99 | 167 | 282 | -216 | -46 | -45 | 847 | 1,242 | 528 |
| Prepaid expenses and other current assets | -8 | 29 | -227 | 136 | -65 | -94 | 81 | -76 | -669 | -265 | 79 | -57 | -6 | -46 | -7 |
| Accounts payable and accrued expenses | 57 | 2 | 99 | -284 | -194 | -188 | 72 | 51 | -7 | -93 | 63 | 33 | 106 | -33 | 125 |
| Accrued compensation | - | - | - | - | - | - | - | - | - | -15 | 63 | 7 | 22 | 29 | -12 |
| Income taxes payable | 49 | -85 | -229 | 78 | -81 | 11 | 333 | 468 | 158 | -193 | -181 | -20 | 94 | -7 | 597 |
| Changes in funded status of retirement plans | - | - | - | - | -58 | -23 | -73 | 21 | 36 | 29 | -9 | 62 | 114 | 45 | 33 |
| Other | 12 | 46 | -39 | 152 | 21 | 68 | 26 | 16 | 107 | 35 | 94 | 52 | 404 | 337 | 401 |
| Cash flows from operating activities | - | - | - | - | - | - | - | - | 7,189 | 6,649 | 6,139 | 8,756 | 8,720 | 6,420 | 6,318 |
| Capital expenditures | 1,199 | 816 | 495 | 412 | 385 | 551 | 531 | 695 | 1,131 | 847 | 649 | 2,462 | 2,797 | 5,071 | 4,820 |
| Proceeds from asset sales | 148 | - | - | - | 142 | 110 | - | 40 | 9 | 30 | 4 | 75 | 3 | 3 | 195 |
| Purchases of short-term investments | 2,510 | 3,653 | 2,802 | 3,907 | 3,107 | 2,767 | 3,503 | 4,555 | 5,641 | 3,444 | 5,786 | 10,124 | 14,483 | 12,705 | 9,716 |
| Proceeds from short-term investments | - | - | 2,198 | 4,249 | 2,966 | 2,892 | 3,390 | 4,095 | 6,708 | 2,310 | 5,545 | 8,478 | 13,657 | 13,387 | 11,187 |
| Other | - | - | - | -46 | -7 | -14 | 6 | 12 | 23 | -32 | 36 | 62 | -37 | -24 | 48 |
| Cash flows from investing activities | - | - | - | - | - | - | - | - | -78 | -1,920 | -922 | -4,095 | -3,583 | -4,362 | -3,202 |
| Proceeds from issuance of long-term debt | - | - | - | - | 498 | 498 | 499 | 1,099 | 1,500 | 1,491 | 1,498 | 1,495 | 1,494 | 3,000 | 2,980 |
| Repayment of debt | - | - | - | - | 1,000 | 1,000 | 1,000 | 625 | 500 | 750 | 500 | 550 | 500 | 500 | 600 |
| Dividends paid | 592 | 644 | 819 | 1,175 | 1,323 | 1,444 | 1,646 | 2,104 | 2,555 | 3,008 | 3,426 | 3,886 | 4,297 | 4,557 | 4,795 |
| Stock repurchases | - | - | 1,800 | 2,868 | 2,831 | 2,741 | 2,132 | 2,556 | 5,100 | 2,960 | 2,553 | 527 | 3,615 | 293 | 929 |
| Proceeds from common stock transactions | 407 | 690 | 523 | 1,314 | 616 | 442 | 472 | 483 | 373 | 539 | 470 | 377 | 241 | 263 | 517 |
| Other | - | - | -10 | -7 | -3 | -3 | -3 | -31 | -47 | -42 | -36 | -46 | -41 | -57 | -53 |
| Cash flows from financing activities | - | - | - | - | - | - | - | - | -6,329 | -4,730 | -4,547 | -3,137 | -6,718 | -2,144 | -2,880 |
| Net change in cash and cash equivalents | - | - | - | - | - | - | - | - | - | -1 | 670 | 1,524 | -1,581 | -86 | 236 |
| Investment Tax Credit Used To Reduce Income Taxes Payable | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 588 |
| Total cash benefit related to the U.S. CHIPS and Science Act | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 588 |